The 20 Best HER2 Negative Breast Cancer Doctors Near Me in Newton, MA

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Katharine Germansky is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Germansky is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, Crohn's Disease, DICER1 Syndrome, and Colonoscopy. Dr. Germansky is board certified in American Board Of Internal Medicine.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

Rochelle Scheib is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Scheib is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Scheib is board certified in Internal Medicine, Medical Oncology, and Hematology.

Nadine Tung is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is board certified in American Board Of Internal Medicine.

Judy Garber is a Hematologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, and Peutz-Jeghers Syndrome.

Douglas Micalizzi is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Micalizzi is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, HER2 Negative Breast Cancer, and Phacomatosis Pigmentokeratotica. Dr. Micalizzi is board certified in Internal Medicine and Medical Oncology.

Z Liu is a Radiologist practicing medicine in Newton, Massachusetts. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Breast Lump, and Breast Infection.

Janeiro Achibiri is a Radiologist practicing medicine in Newton, Massachusetts. Dr. Achibiri is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses Breast Lump, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Giant Mammary Hamartoma.

Keyan Salari is a Urologist practicing medicine in Newton, Massachusetts. Dr. Salari is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery. Dr. Salari is board certified in Urology.

Suma Chandra is a Radiologist practicing medicine in Newton, Massachusetts. Dr. Chandra is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses Breast Lump, BRCA Positive Breast Cancer, and HER2 Negative Breast Cancer.

Bryann Bromley is a Radiologist and a Neonatologist practicing medicine in Brookline, Massachusetts. Dr. Bromley is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cysts, Neonatal Ovarian Cyst, Angiomyoma, Uterine Fibroids, and Intrauterine Device Insertion.

Dr. Sammons is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer. She has led multiple clinical trials which have led to new treatment options for patients with metastatic breast cancer. She also has expertise in the treatment of brain metastases. Dr. Sammons received her MD from Sidney Kimmel Medical College in Philadelphia, PA in 2012. She completed her residency in internal medicine at University of Maryland and went on to complete fellowship in medical oncology and hematology at Duke University. In 2018, she joined the staff of Duke Cancer Institute and ultimately served as Associate Director of Breast Cancer Research. She joined Brigham and Women's and Dana-Farber in 2022, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. She serves as Associate Director of the Metastatic Breast Cancer Program. Dr. Sammons is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Paget Disease of the Breast. Dr. Sammons is board certified in Internal Medicine and Medical Oncology.

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Nakhlis is board certified in Surgery, General.

Gerburg Wulf is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Wulf is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is board certified in American Board Of Internal Medicine.

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Mayer is board certified in Medical Oncology.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Lynce is board certified in Medical Oncology.

Susan Schumer is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Schumer is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Schumer is board certified in Medical Oncology.

Dr. Schlam received her medical degree from Anahuac University in Mexico City in 2014. She subsequently completed her Internal Medicine residency at The Jewish Hospital of Cincinnati and then her Hematology and Medical Oncology fellowship at The MedStar Georgetown Washington Hospital Center in Washington, DC. She obtained her Masters in Public Health from the Harvard School of Public Health in 2024. She was faculty at Tufts Medical Center from 2021 to 2024. In 2024, she joined the staff of the Dana-Farber Cancer Institute as a breast medical oncologist and clinical researcher. Her research focuses on drug development, identifying markers of response to novel therapies and healthcare disparities. Dr. Camhi is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Camhi is board certified in Internal Medicine, Hematology, and Medical Oncology.